Buprenorphine Use for Analgesia in Palliative Care.  Jackson LK, Poon IO, Garcia MA, Imam S, Braun UK.  Pharmacy (Basel). 2024 May 13;12(3):78. doi: 10.3390/pharmacy12030078. PMID: 38804470; PMCID: PMC11130940. https://www.ncbi.nlm.nih…

Surgical removal of extended-release buprenorphine depot due to adverse reactions.  Burton A, DeBona DJ, Handzel M, Kelly-Pisciotti S, Qiao M, Rojek D, Acquisto NM.  Am J Emerg Med. 2024 Apr 27;81:127-128. doi: 10.1016/j.ajem.2024.04.047…

Development and verification of a full physiologically-based pharmacokinetic model for sublingual buprenorphine in healthy adult volunteers that accounts for nonlinear bioavailability.  van Hoogdalem MW, Tanaka R, Johnson TN, Vinks AA, Mizuno…

Reduced emergency department use among insured individuals receiving extended-release buprenorphine in a health system setting.  Yarborough BJH, Stumbo SP, Janoff SL, Keast EM, Leo MC, Leitz SJ.  Drug Alcohol Depend Rep. 2024 Apr 7;11:10…

The Effectiveness of Buprenorphine Transdermal Patch and Low Dose Sublingual Buprenorphine Induction to Transition to Long-Acting Subcutaneous Buprenorphine Injection in Opioid Use Disorder in Inpatient Setting.  Gorham JW, Ansari F, Sethi R.&…

Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder.  Walsh SL, Comer SD, Zdovc JA, Sarr C, Björnsson M, Strandgården K, Hjelmström P, Tiberg F…